These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 10321503)

  • 1. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.
    Conley BA; Egorin MJ; Tait N; Rosen DM; Sausville EA; Dover G; Fram RJ; Van Echo DA
    Clin Cancer Res; 1998 Mar; 4(3):629-34. PubMed ID: 9533530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
    Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines.
    Su J; He L; Zhang N; Ho PC
    J Pharmacol Exp Ther; 2006 Jan; 316(1):62-70. PubMed ID: 16188956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug.
    Edelman MJ; Bauer K; Khanwani S; Tait N; Trepel J; Karp J; Nemieboka N; Chung EJ; Van Echo D
    Cancer Chemother Pharmacol; 2003 May; 51(5):439-44. PubMed ID: 12736763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice.
    Eiseman JL; Yuan ZM; Eddington ND; Sentz DL; Callery PS; Egorin MJ
    Cancer Chemother Pharmacol; 1996; 38(1):13-20. PubMed ID: 8603446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
    Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
    Drug Metab Dispos; 1996 Aug; 24(8):911-21. PubMed ID: 8869828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of tributyrin and its metabolite butyrate in Wistar rat plasma samples by gas chromatography/mass spectrometry.
    Su J; Zhang N; Ho PC
    Rapid Commun Mass Spectrom; 2004; 18(19):2217-22. PubMed ID: 15384139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.